Thrombolex Raises $50 Million Series A Financing Led by OrbiMed

Endologix Acquires Pounce Thrombectomy System From Surmodics

May 20, 2026

Medical Devices

Endologix, a privately held medical device company, announced it will acquire the Pounce Thrombectomy System from Surmodics. The FDA-cleared, fully mechanical peripheral thrombectomy platform is intended to complement Endologix’s existing vascular intervention portfolio and expand the continuum of care for patients with peripheral vascular disease.

QIA Leads $250M Financing in Kardium to Support Commercial Launch

July 2, 2025

Medical Devices

Kardium Inc., a Vancouver/Burnaby-based medical device company developing the Globe Pulsed Field System for atrial fibrillation, raised USD 250 million in a financing round led by the Qatar Investment Authority (QIA). The growth-capital raise, which included new investors Janus Henderson Investors, MM Capital, Piper Heartland Healthcare Capital, Eventide Asset Management, Eckuity Capital and participation from existing investors such as T. Rowe Price and Durable Capital, will fund regulatory approvals, the commercial launch and expansion of manufacturing capabilities.

Lomond Therapeutics Completes Reverse Merger with Venetian-1 and Raises $44M

November 4, 2024

Biotechnology

Lomond Therapeutics completed a reverse merger with Venetian-1 Acquisition Corp., which changed its name to Lomond Therapeutics Holdings, Inc., and closed a $44 million private placement led by existing and new investors. The financing included participation from OrbiMed, Torrey Pines Investment, Deerfield Management, American Financial Group and Heights Capital and will fund advancement of Lomond’s clinical-stage oncology programs (lomonitinib, lonitoclax and a menin inhibitor).

Medix Infusion Raises $35M Series B Led by Echo Health Ventures and Acquires Infusion Operations of the Center for Neurology and Spine

January 9, 2023

Healthcare Services

Medix Infusion closed a $35 million Series B led by Echo Health Ventures with participation from Pittco Direct Investments II and Noro-Moseley Partners, and simultaneously secured a debt facility with Live Oak Bank. Medix will use the capital to support organic growth and to acquire the infusion operations of the Center for Neurology and Spine, expanding its ambulatory infusion footprint into Arizona.

Cyrus Biotechnology Acquires Orthogonal Biologics and Raises $18M Series B

December 6, 2021

Biotechnology

Cyrus Biotechnology completed an acquisition of Orthogonal Biologics and closed an $18 million Series B financing to build an integrated software-and-screening pre-clinical biologics discovery firm. The financing was led by a syndicate including OrbiMed Advisors, Trinity Ventures, Agent Capital and other investors, with Selecta Bioscience joining as a strategic investor; the acquisition brings Orthogonal’s deep mutational scanning protein engineering capabilities into Cyrus’s computational discovery platform.

Surmodics Acquires Vetex Medical Limited

July 6, 2021

Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) acquired Galway-based Vetex Medical Limited to expand its thrombectomy portfolio with the ReVene Thrombectomy Catheter. The deal included an upfront payment of $39.9 million and up to $7 million in additional milestone payments (with $3.5 million guaranteed), giving Surmodics a second FDA 510(k)-cleared mechanical thrombectomy device and IP to accelerate its thrombectomy platform development.